Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesCipla Limited8.68871790481270.5954
Domestic EquitiesSun Pharmaceutical Industries Limited8.47941535592264.0758
Domestic EquitiesIPCA Laboratories Limited7.72881696381240.6995
Domestic EquitiesLaurus Labs Limited6.52001832618203.0541
Domestic EquitiesSai Life Sciences Limited5.22771792251162.8081
Domestic EquitiesGland Pharma Limited5.0907920673158.5399
Domestic EquitiesCohance Lifesciences Limited5.03702967600156.8673
Domestic EquitiesApollo Hospitals Enterprise Limited4.4043194767137.1647
Domestic EquitiesAlembic Pharmaceuticals Limited3.88031428180120.8455
Domestic EquitiesPfizer Limited3.2134200644100.0752
Domestic EquitiesVijaya Diagnostic Centre Limited3.187293553099.2597
Domestic EquitiesKovai Medical Center and Hospital Limited3.050116515694.9886
Domestic EquitiesProcter & Gamble Health Limited2.916915928890.8419
Domestic EquitiesIndoco Remedies Limited2.4358323347475.8573
Domestic EquitiesConcord Biotech Limited2.116248977465.9040
Domestic EquitiesEmcure Pharmaceuticals Limited1.700438808752.9545
Domestic EquitiesICICI Lombard General Insurance Company Limited1.521024141347.3676
Domestic EquitiesUnichem Laboratories Limited1.208985206337.6484
Domestic EquitiesAarti Drugs Limited1.126485215535.0790
Domestic EquitiesNephrocare Health Services Limited0.955663498329.7617
Domestic EquitiesAlkem Laboratories Limited0.66013733420.5580
Domestic EquitiesCorona Remedies Limited0.520211697016.1992
Domestic EquitiesMedplus Health Services Limited0.497919207815.5065
Domestic EquitiesJupiter Life Line Hospitals Limited0.42119411713.1143
Domestic EquitiesLaxmi Dental Limited0.24532804017.6395
Domestic EquitiesThyrocare Technologies Limited0.0609425731.8975
Total 80.8940 2519.3032
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments1.1503 35.8228
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.1266 -3.9419
Total 1.0237 31.8809
Overseas EquitiesGlobus Medical Inc6.7762268800211.0321
Overseas EquitiesIllumina Inc6.0743160400189.1739
Overseas EquitiesIntuitive Surgical Inc3.06901876895.5798
Overseas EquitiesAbbott Laboratories1.14313160035.6007
Overseas EquitiesGrail Inc0.215887336.7211
Total 17.2785 538.1076
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.80396125025.0354
Total 0.8039 25.0354
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.